The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis
Open accessAbstract
Experiments were designed to test the hypothesis that chronic exposure to tumor necrosis factor alpha (TNF) alters the function of activated T lymphocytes. Pretreatment of tetanus toxoid-specific T cell clones with TNF for up to 16 d impaired rechallenge proliferative responses to antigen in a dose- and time-dependent fashion. IL-2 and PHA responses were preserved. Prolonged treatment with TNF impaired production of IL-2, IL-10, IFN gamma, TNF, and lymphotoxin (LT) following stimulation with immobilized OKT3, and resulted in suboptimal expression of the IL-2R alpha chain (Tac) but not CD3, CD4, or HLA-DR antigens, when compared to untreated control cells. By contrast, pretreatment of T cells for prolonged periods in vitro with neutralizing anti-TNF monoclonal antibodies (mAb) enhanced proliferative responses, increased lymphokine production, and upregulated Tac expression following stimulation with OKT3. To determine whether TNF exerts immunosuppressive effects on T cells in vivo, we studied cell-mediated immunity in patients with active rheumatoid arthritis (RA), before and after treatment with a chimeric anti-TNF mAb. Treatment with anti-TNF restored the diminished proliferative responses of PBMC to mitogens and recall antigens towards normal in all patients tested. These data demonstrate that persistent expression of TNF in vitro and in vivo impairs cell-mediated immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since inflammatory cytokines that direct T cell subtype production are altered in depressed patients (12–14)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [14]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,753
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.5.1209 · Cited by 3,762
Ding, A. H., Nathan, C., & Stuehr, D. J. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2407 · Cited by 2,840
The Biology Of Cachectin/TNF: A Primary Mediator Of The Host Response
Beutler, B., & Cerami, A. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.003205 · Cited by 1,690
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.
Keffer, J., Probert, L., Cazlaris, H. E., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,670
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
Kindler, V., Sappino, A., Grau, G. E., Piguet, P., & VASSALLI, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,239
Dayer, J., Beutler, B., & Cerami, A. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,208
Research works printed but not linked: 1
- Hart, P. H., G. F. Vitti, D. R. Burgess, G. A. Whitty, D. S. Piccoli, and J. H. Hamilton. 1989. Potential anti-inflammatory effects of interleukin-4: Suppression of human monocyte tumor necorsis factor a, interleukin-1, and pros- taglandin E2. Proc. Natl. Acad. Sci. USA. 86:3803-3807.
Cited by
Sorted by citations
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,507
Self-citationElliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Self-citationTumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D. E., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,658
TFOS DEWS II Management and Therapy Report
Jones, L., Downie, L. E., Korb, D. R., Benitez-del-Castillo, J., Dana, R., Deng, S. X., Dong, P. N., Geerling, G., Hida, R. Y., Liu, Y., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.006 · Cited by 1,506
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,252
Self-citationImmune system to brain signaling: Neuropsychopharmacological implications
Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195
Arend, W. P., & Dayer, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380202 · Cited by 891
D’Haens, G., van Deventer, S. J. H., van Hogezand, R. A., Chalmers, D. M., Kothe, C., Baert, F., Braakman, T., Schaible, T. F., Geboes, K., & Rutgeerts, P. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70005-3 · Cited by 744
Development of anti-TNF therapy for rheumatoid arthritis
Feldmann, M. (2002) · Nature reviews. Immunology · doi:10.1038/nri802 · Cited by 667
Self-citationRole of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
Feldmann, M., & Maini, S. R. N. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00626.x · Cited by 387
Self-citationDepression and immunity: A role for T cells?
Miller, A. H. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.09.009 · Cited by 345
Neuroplastic changes in depression: A role for the immune system
Eyre, H., & Baune, B. T. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.019 · Cited by 319
The paradigm of Th1 and Th2 cytokines
Singh, V. K., Mehrotra, S., & Agarwal, S. S. (1999) · Immunologic Research · doi:10.1007/bf02786470 · Cited by 316
Ljung, T., Karlén, P., Schmidt, D., Hellström, P. M., Lapidus, A., Janczewska, I., Sjöqvist, U., & Löfberg, R. (2004) · Gut · doi:10.1136/gut.2003.018515 · Cited by 314
Mauri, C., Williams, R. O., Walmsley, M. J., & Feldmann, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260716 · Cited by 309
Self-citationChronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling
Cope, A. P., Liblau, R. S., Yang, X.-D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L., Kollias, G., & McDevitt, H. O. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1573 · Cited by 287
Self-citationDesign of effective immunotherapy for human autoimmunity
Feldmann, M., & Steinman, L. (2005) · Nature · doi:10.1038/nature03727 · Cited by 283
Self-citationAnkylosing spondylitis and bowel disease
Rudwaleit, M., & Baeten, D. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.03.010 · Cited by 275
Inflammatory T helper 17 cells promote depression-like behavior in mice
Beurel, E., Harrington, L. E., & Jope, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.021 · Cited by 254
Zein, N. N., & for the Etanercept Study Group (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.11.025 · Cited by 247
Hestad, K. A., Tønseth, S., Støen, C. D., Ueland, T., & Aukrust, P. (2003) · The Journal of ECT · doi:10.1097/00124509-200312000-00002 · Cited by 235
Anti-Tumor Necrosis Factor-α Therapy of Rheumatoid Arthritis
Feldmann, M., Elliott, M. J., Maini, R. N., & Woody, J. N. (1997) · Advances in immunology · doi:10.1016/s0065-2776(08)60891-3 · Cited by 224
Self-citationBrennan, F. M., & Feldmann, M. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80018-5 · Cited by 226
Self-citationBiologic therapies in rheumatology: lessons learned, future directions
Strand, V., Kimberly, R. P., & Isaacs, J. D. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2196 · Cited by 223
Clinical Experience With Infliximab Therapy in 100 Patients With Crohn's Disease
Farrell, R. J., Shah, S. A., Lodhavia, P. J., Alsahli, M., Falchuk, K. R., Michetti, P., & Peppercorn, M. A. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03366.x · Cited by 209
The relationship between infliximab treatment and lymphoma in Crohn's disease
Bickston, S. J., Lichtenstein, G. R., Arseneau, K. O., Cohen, R. B., & Cominelli, F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70294-5 · Cited by 204
Cornillie, F. J., Shealy, D. J., D’Haens, G., Geboes, K. J., Assche, G. V., Ceuppens, J. L., Wagner, C. L., Schaible, T., Plevy, S. E., Targan, S. R., et al. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00956.x · Cited by 202
Matsuno, H., Yudoh, K., Katayama, R., Nakazawa, F., Uzuki, M., Sawai, T., Yonezawa, T., Saeki, Y., Panayi, G. S., Pitzalis, C., et al. (2002) · Lara D. Veeken · doi:10.1093/rheumatology/41.3.329 · Cited by 200
The role of tumour necrosis factor (TNF-α) in experimental autoimmune uveoretinitis (EAU)
Dick, A. D., Forrester, J. V., Liversidge, J., & Cope, A. P. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.06.005 · Cited by 197
Self-citationCalabrese, L. H., Zein, N., & Vassilopoulos, D. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.028209 · Cited by 197
Andreakos, E., Foxwell, B. M. J., & Feldmann, M. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00202.x · Cited by 191
Self-citationPATHOGENESIS OF RHEUMATOID ARTHRITIS
Panayi, G. S., Corrigall, V., & Pitzalis, C. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70204-0 · Cited by 187
The role of tumor necrosis factor-alpha in systemic lupus erythematosus
Aringer, M., & Smolen, J. S. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2341 · Cited by 177
Cytokines and anti-cytokine biologicals in autoimmunity: present and future
Andreakos, E., Foxwell, B. M. J., Brennan, F. M., Maini, R. N., & Feldmann, M. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00018-7 · Cited by 171
Self-citationCellular and Humoral Mechanisms Involved in the Control of Tuberculosis
Zúñiga, J., Torres‐García, D., Santos-Mendoza, T., Rodrı́guez-Reyna, T. S., Granados, J., & Yunis, E. J. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/193923 · Cited by 176
Role of cytokines, acute-phase proteins, and chemokinesin the progression of rheumatoid arthritis
Badolato, R., & Oppenheim, J. J. (1996) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(96)80041-2 · Cited by 162
Aukrust, P., Lien, E., Kristoffersen, A., Müller, F., Haug, C. J., Espevik, T., & Ss, F. (1996) · Blood · doi:10.1182/blood.v87.2.674.bloodjournal872674 · Cited by 152
Kapetanovic, M. C., Roseman, C., Jonsson, G. G., Truedsson, L., Saxne, T., & Geborek, P. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30580 · Cited by 147
Crnkic Kapetanovic, M., Saxne, T., Jönsson, G., Truedsson, L., & Geborek, P. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4358 · Cited by 142
Generini, S., Giacomelli, R., Fedi, R., Fulminis, A., Pignone, A. M., Frieri, G., Rosso, A. D., Viscido, A., Galletti, B., Fazzi, M., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012450 · Cited by 142
Studies of T-cell activation in chronic inflammation.
Cope, A. P. (2002) · Arthritis Research · doi:10.1186/ar557 · Cited by 137
Self-citationThe cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells
Perucha, E., Melchiotti, R., Bibby, J. A., Wu, W. H., Frederiksen, K. S., Roberts, C. A., Hall, Z., Friec, G. L., Robertson, K. A., Lavender, P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08332-9 · Cited by 132
Self-citationRegulation of autoimmunity by proinflammatory cytokines
Cope, A. P. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80087-3 · Cited by 136
Self-citationMa, H., Napierata, L., Stedman, N., Benoit, S., Collins, M. A., Nickerson‐Nutter, C. L., & Young, D. A. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27203 · Cited by 130
Zou, J., Rudwaleit, M., Brandt, J., Thiel, A., Braun, J., & Sieper, J. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.6.561 · Cited by 129
Vielhauer, V., & Mayadas, T. N. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.02.004 · Cited by 125
Bo, X., Broome, U., Remberger, M., & Sumitran-Holgersson, S. (2001) · Gut · doi:10.1136/gut.49.1.131 · Cited by 120
Bondeson, J. (1997) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(96)00419-3 · Cited by 116
Isomäki, P., Panesar, M., Annenkov, A. E., Clark, J. M., Foxwell, B. M. J., Chernajovsky, Y., & Cope, A. P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5495 · Cited by 119
Self-citationInterleukin-7 induced immunopathology in arthritis
Hartgring, S. A. Y., Bijlsma, J. W. J., Lafeber, F. P. J. G., & van Roon, J. A. G. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058479 · Cited by 117
Therapeutic blockade of TNF in patients with SLE—Promising or crazy?
Aringer, M., & Smolen, J. S. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.001 · Cited by 117
TNF-α blockade induces IL-10 expression in human CD4+ T cells
Evans, H. G., Roostalu, U., Walter, G. J., Gullick, N., Frederiksen, K. S., Roberts, C. A., Sumner, J., Baeten, D., Gerwien, J. G., Cope, A. P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4199 · Cited by 119
Self-citationMesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis
Παπαδοπούλου, Α., Yiangou, M., Athanasiou, E., Ζώγας, Ν., Kaloyannidis, P., Batsis, I., Fassas, Α., Anagnostopoulos, Α., & Yannaki, E. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200985 · Cited by 116
Aukrust, Müller, Ueland, Svardal, Berge, & Frøland (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00619.x · Cited by 109
Bench-to-bedside strategies for osteoporotic fracture: From osteoimmunology to mechanosensation
Xie, Y., Zhang, L., Xiong, Q., Gao, Y., Ge, W., & Tang, P. (2019) · Bone Research · doi:10.1038/s41413-019-0066-7 · Cited by 107
Monoclonal Antibodies: Past, Present and Future
Posner, J., Barrington, P. J., Brier, T., & Datta‐Mannan, A. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_323 · Cited by 120
Tartour, É., Latour, S., Mathiot, C., Thiounn, N., Mosseri, V., Joyeux, I., d’Enghien, C. D., Lee, R., Debré, B., & Fridman, W. H. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630210 · Cited by 104
Zou, J., Rudwaleit, M., Brandt, J., Thiel, A., Braun, J., & Sieper, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10847 · Cited by 103
Recent developments in the immunobiology of rheumatoid arthritis
Andersson, A. K., Li, C. L., & Brennan, F. M. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2370 · Cited by 98
Self-citationChen, X., & Oppenheim, J. J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.04.025 · Cited by 97
Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management
Viganò, M., Degasperi, E., Aghemo, A., Lampertico, P., & Colombo, M. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.646986 · Cited by 98
Lin, S., Kennedy, N. A., Saifuddin, A., Sandoval, D. M., Reynolds, C. J., Seoane, R. C., Kottoor, S. H., Pieper, F. P., Lin, K., Butler, D. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28517-z · Cited by 103
What does tumour necrosis factor excess do to the immune system long term?
Clark, J., Vagenas, P., Panesar, M., & Cope, A. P. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.042523 · Cited by 93
Self-citationImpaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα
Baeten, D., Damme, N. V., den Bosch, F. V., Kruithof, E., Vos, M. D., Mielants, H., Veys, E. M., & Keyser, F. D. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.8.750 · Cited by 93
Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases
Williams, R. O., Paleolog, E. M., & Feldmann, M. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.06.001 · Cited by 95
Self-citationTumor necrosis factor-α as a therapeutic target for diabetic nephropathy
Navarro‐González, J. F., Jarque, A., Muros, M., Fernández, C. M., & Garcı́a, J. G. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.02.005 · Cited by 89
GENETICS OF SYSTEMIC LUPUS ERYTHEMATOSUS
Sullivan, K. E. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70137-x · Cited by 89
Berg, L., Lampa, J., Rogberg, S., van Vollenhoven, R., & Klareskog, L. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.2.133 · Cited by 88
Dionne, S., DʼAgata, I. D., Hiscott, J. B., Vanounou, T., & Seidman, E. G. (1998) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1998.00595.x · Cited by 86
Stress-Related Immune Markers in Depression: Implications for Treatment
Hughes, M. M., Connor, T. J., & Harkin, A. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw001 · Cited by 91
Pyoderma Gangrenosum Associated with Crohn Disease: Effect of TNF- α Blockade with Infliximab
Ljung, T., Staun, M., Grove, O., FAUSA, O., Vatn, M. H., & Hellström, P. M. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202320378338 · Cited by 83
Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases
Beurel, E. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00018 · Cited by 82
Siddiqui, M. A. A., & Scott, L. J. (2005) · Drugs · doi:10.2165/00003495-200565150-00014 · Cited by 80
Spencer, M. J., Marino, M. W., & Winckler, W. (2000) · Neuromuscular Disorders · doi:10.1016/s0960-8966(00)00160-7 · Cited by 79
Marinescu, R. C., NYCE, K. B., de la Peña, L. S., Overhauser, J., & Williams, C. J. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199910)42:10 · Cited by 13
Sivamani, R. K., Goodarzi, H., Garcia, M. S., Raychaudhuri, S. P., Wehrli, L. N., Ono, Y., & Maverakis, E. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8301-7 · Cited by 81
Quattrocchi, E., Walmsley, M. J., Browne, K. A., Williams, R. O., Marinova-Mutafchieva, L., Buurman, W. A., Butler, D. M., & Feldmann, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.1000 · Cited by 76
Self-citationDistinct chemokine receptor and cytokine expression profile in secondary progressive MS
Sørensen, T. L., & Sellebjerg, F. T. (2001) · Neurology · doi:10.1212/wnl.57.8.1371 · Cited by 74
Aithal, G. P., & Mansfield, J. C. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01023.x · Cited by 72
Fritsch-Stork, R. D. E., Eselböck, D., Skriner, K., Jahn‐Schmid, B., Scheinecker, C., Bohle, B., Tohidast-Akrad, M., Hayer, S., Neumüller, J., Piñol-Roma, S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.1068 · Cited by 72
Gut inflammation and spondyloarthropathies
Keyser, F. D., Baeten, D., den Bosch, F. E. V., Vos, M. D., Cuvelier, C. A., Mielants, H., & VEYS, E. M. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0061-6 · Cited by 71
Ohshima, S., Saeki, Y., Mima, T., Sasai, M., Nishioka, K., Ishida, H., Shimizu, M., Suemura, M., McCloskey, R. V., & Kishimoto, T. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020543625282 · Cited by 70
Cytokine inhibitors in autoimmune disease
Weckmann, A. L., & Alcocer-Varela, J. C. (1996) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(96)80042-4 · Cited by 71
Both T-Helper-1- and T-Helper-2-Type Lymphokines Are Depressed in Posttrauma Anergy
Puyana, J. C., Pellegrini, J. D., De, A. K., Kodys, K., Silva, W. E., & Miller, C. L. (1998) · doi:10.1097/00005373-199806000-00017 · Cited by 68
Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation
Rouhani, F. N., Meitin, C. A., Kaler, M. M., Hilligoss, D. M., Stylianou, M. P., & Levine, S. J. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.02.031 · Cited by 67
Kashiwada, M., Cattoretti, G., McKeag, L., Rouse, T. M., Showalter, B. M., Al‐Alem, U., Niki, M., Pandolfi, P. P., Field, E. H., & Rothman, P. B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3958 · Cited by 66
Biologic Therapy for Inflammatory Bowel Disease
Sands, B. E. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030206 · Cited by 63
Baldwin, H. M., Ito‐Ihara, T., Isaacs, J. D., & Hilkens, C. M. U. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.110502 · Cited by 62
Yannaki, E., Παπαδοπούλου, Α., Athanasiou, E., Kaloyannidis, P., Paraskeva, A., Bougiouklis, D., Palladas, P., Yiangou, M., & Anagnostopoulos, Α. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27690 · Cited by 61
Smeets, T. J. M., Dolhain, R. J. E. M., Miltenburg, A. M. M., de Kuiper, R., Breedveld, F. C., & Tak, P. P. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4525 · Cited by 61
Modulation of allergic inflammation in mice deficient in TNF receptors
Rudmann, D. G., Moore, M. W., Tepper, J. S., Aldrich, M. C., Pfeiffer, J. W., HogenEsch, H., & Tumas, D. B. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1047 · Cited by 61
Cytokine production profile in patients with Behcet's disease treated with infliximab
Misumi, M., Hagiwara, E., Takeno, M., Takeda, Y., Inoue, Y., Tsuji, T., Ueda, A., Nakamura, S., Ohno, S., & Ishigatsubo, Y. (2003) · Cytokine · doi:10.1016/j.cyto.2003.09.003 · Cited by 60
Ji, Y. W., Byun, Y. J., Choi, W., Jeong, E., Kim, J. S., Noh, H., Kim, E. S., Song, Y. J., Park, S. K., & Lee, H. K. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11515 · Cited by 59
Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus
Aringer, M., & Smolen, J. S. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.4.411 · Cited by 59
Byström, J., Clanchy, F. I. L., Taher, T. E. I., Mangat, P. K., Jawad, A. S., Williams, R. O., & Mageed, R. A. (2016) · Cytokine · doi:10.1016/j.cyto.2016.09.001 · Cited by 58
Dimitrov, S., Besedovsky, L., Born, J., & Lange, T. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.11.017 · Cited by 56
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
Sakaguchi, S., Benham, H., Cope, A. P., & Thomas, R. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.4 · Cited by 54
Self-citationTaylor, K. R., Mills, R. E., Costanzo, A. E., & Jameson, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011422 · Cited by 59
Habil, N., Abate, W., Beal, J., & Foey, A. (2014) · Beneficial Microbes · doi:10.3920/bm2013.0061 · Cited by 55
Metadata
- Authors
- Cope, A. P., Londei, M., Chu, N. R., Cohen, S. B., Elliott, M. J., Brennan, F. M., Maini, R. N., & Feldmann, M.
- Affiliations
- Kennedy Institute of Rheumatology (GB)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 1994-08-01
- Volume
- 94
- Issue
- 2
- Pages
- 749-760
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC296155
- OpenAlex
- W1985680749
- Cited by
- 243
- References
- 60
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2019: 9 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 7 · 2012: 10
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Medical Research Council
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- TNF-α, T cell activation, T cell receptor/CD3 complex, anti-TNF monoclonal antibody, rheumatoid arthritis, cell-mediated immunity, immunosuppression, IL-2 receptor alpha chain, OKT3, lymphokine production, T cell clones
- MeSH terms
- Antibodies, Monoclonal, Antigen-Presenting Cells, Arthritis, Rheumatoid, Cells, Cultured, Dose-Response Relationship, Drug, HLA-DR Antigens, Humans, Interleukin-2, Lymphocyte Activation, Lymphokines, T-Lymphocytes, Tumor Necrosis Factor-alpha, CD4 Antigens, Receptor-CD3 Complex, Antigen, T-Cell
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
